These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 10572812)
1. Candidates for thrombolytic treatment in acute ischaemic stroke--where are our patients in Hong Kong? Siu YC; Wong TW; Lau CC J Accid Emerg Med; 1999 Nov; 16(6):412-7. PubMed ID: 10572812 [TBL] [Abstract][Full Text] [Related]
2. [Thrombolytic therapy in patients with acute brain infarction: favorable preliminary results in Maastricht]. Boiten J; Wilmink JT; Lodder J; Troost J Ned Tijdschr Geneeskd; 2000 May; 144(22):1062-9. PubMed ID: 10850109 [TBL] [Abstract][Full Text] [Related]
3. Intra-arterial revascularisation therapy for acute ischaemic stroke: initial experience in a Hong Kong hospital. Wong EH; Yu SC; Lau AY; Hui VS; Leung CS; Hui JW; Siu DY; Abrigo JM; Lee KT; Graham CA; Wong LK; Leung TW Hong Kong Med J; 2013 Apr; 19(2):135-41. PubMed ID: 23535673 [TBL] [Abstract][Full Text] [Related]
4. The association of blood pressure and collateral circulation in hyperacute ischemic stroke patients treated with intravenous thrombolysis. Rusanen H; Saarinen JT; Sillanpää N Cerebrovasc Dis; 2015; 39(2):130-7. PubMed ID: 25660943 [TBL] [Abstract][Full Text] [Related]
5. Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience. Rhoney DH; Coplin WM; Lin Y; Frankel M; Lyden PD; Levine SR J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):40-8. PubMed ID: 20123226 [TBL] [Abstract][Full Text] [Related]
6. Intravenous thrombolysis for acute ischaemic stroke in a hospital without a specialised neuro-intensive care unit. Wiegand N; Lüthy R; Vogel B; Straumann E; Beynon C; Bertel O; Oelz O; Caspar CB Swiss Med Wkly; 2004 Jan; 134(1-2):14-7. PubMed ID: 14745662 [TBL] [Abstract][Full Text] [Related]
7. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset. Lorenzano S; Toni D; Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526 [TBL] [Abstract][Full Text] [Related]
8. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke. Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445 [TBL] [Abstract][Full Text] [Related]
9. Posterior circulation stroke is associated with prolonged door-to-needle time. Sarraj A; Medrek S; Albright K; Martin-Schild S; Bibars W; Vahidy F; Grotta JC; Savitz SI Int J Stroke; 2015 Jul; 10(5):672-8. PubMed ID: 23521891 [TBL] [Abstract][Full Text] [Related]
10. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience. Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460 [TBL] [Abstract][Full Text] [Related]
11. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke. Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742 [TBL] [Abstract][Full Text] [Related]
12. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry. Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276 [TBL] [Abstract][Full Text] [Related]
13. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451 [TBL] [Abstract][Full Text] [Related]
14. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes. Williams JM; Navin TJ; Jude MR; Levi CR Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520 [TBL] [Abstract][Full Text] [Related]
15. Predictive value of the Cincinnati Prehospital Stroke Scale for identifying thrombolytic candidates in acute ischemic stroke. You JS; Chung SP; Chung HS; Lee HS; Park JW; Kim HJ; Lee SH; Park I; Lee HS Am J Emerg Med; 2013 Dec; 31(12):1699-702. PubMed ID: 24055479 [TBL] [Abstract][Full Text] [Related]
16. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience. Salam KA; Ummer K; Pradeep Kumar VG; Noone ML Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667 [TBL] [Abstract][Full Text] [Related]
17. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital. Hsu YC; Sung SF; Ong CT; Wu CS; Su YH Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569 [TBL] [Abstract][Full Text] [Related]
18. Thrombolysis beyond 3 hours for acute ischaemic stroke. Selvaratnam R; Srirangalingam U; Ahmad S; Goulden P Emerg Med J; 2009 Oct; 26(10):756-7. PubMed ID: 19773512 [TBL] [Abstract][Full Text] [Related]